Results 121 to 130 of about 10,744 (193)

[Characteristics of patients with systemic sclerosis who develop interstitial lung disease]. [PDF]

open access: yesRev Med Inst Mex Seguro Soc, 2023
Fajardo-Hermosillo LD   +2 more
europepmc   +1 more source

[Tubercular panuveitis, can SARS-CoV-2 re-emerge opportunistic diseases?] [PDF]

open access: yesRev Esp Geriatr Gerontol, 2021
Gil García B   +5 more
europepmc   +1 more source

Tratamiento inmunosupresor de la miastenia gravis con tacrolimus (FK506)

open access: yes, 2006
La miastenia gravis es una enfermedad autoinmune mediada por anticuerpos anti-receptor de acetilcolina del músculo esquelético. Su tratamiento incluye: La timectomia y la inmunosupresión con los corticoides, la azatioprina y la ciclosporina. Estos inmunosupresores son efectivos, pero el manejo de los pacientes con miastenia gravis generalizada ...
openaire   +1 more source

[Current Status of Passive Immunization Against COVID in Respiratory Patients]. [PDF]

open access: yesOpen Respir Arch
Mora Cuesta VM   +2 more
europepmc   +1 more source

[Pneumocystis pneumonia in rheumatoid arthritis treated with biologics: A case report]. [PDF]

open access: yesOpen Respir Arch, 2021
Méndez Salazar F   +5 more
europepmc   +1 more source

Inmunosupresor basado en la interrupción de la interacción TCR-Nck

open access: yes, 2008
Consejo Superior de Investigaciones Científicas (España)
Alarcón, Balbino   +3 more
openaire   +2 more sources

[Evaluation of the management of Clostridioides difficile infection as a risk factor for recurrence. A retrospective observational study]. [PDF]

open access: yesRev Esp Quimioter
Barbero Allende JM   +22 more
europepmc   +1 more source

[Uterine Transplant. You are my Family Doctor and I Need your Opinion]. [PDF]

open access: yesAten Primaria
Leal Hernández M   +3 more
europepmc   +1 more source

[Whipple's disease with multiple presentation in a rheumatologic patient]. [PDF]

open access: yesRev Esp Quimioter, 2023
Fernández Vecilla D   +3 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy